Men's health addresses care gaps for men aged 18-50, focusing on early intervention to prevent serious conditions. Sexual health and fertility issues often motivate men to seek medical care, ...

PARP Inhibitors in Metastatic Prostate Cancer: Efficacy, Trials, and Combination Therapies ...

CVAC device uses continuous irrigation and aspiration to improve kidney stone removal outcomes. Traditional kidney stone surgeries have seen limited technological advancements beyond scope sizes and ...

Focal therapy for prostate cancer has shifted from skepticism to optimism over the past decade. Community-based practitioners and academic programs are increasingly adopting focal therapy. The ...

PARP Inhibitors in Metastatic Prostate Cancer: Efficacy, Trials, and Combination Therapies ...

Posluma, a new PSMA-based tracer, will improve patient assessment for PSMA-based therapies like Lutetium-based theranostics. Dosimetry integration will enhance precision in identifying lesions and ...

The meeting featured international societies and the first Spanish language abstract session, enhancing global collaboration in sexual medicine. Instructional courses covered topics like androgens, ...

Bone scans have been the standard for staging metastatic prostate cancer due to their ability to detect bone metastases indirectly. PSMA-PET offers superior specificity and accuracy compared to bone ...

The TENACIO pump showed significantly faster completion times and greater efficiency than the MS pump in ex-vivo tasks. Surface electromyography was used to measure muscular effort, normalized to ...

Urologists should prioritize discussions about sexual health with female bladder cancer patients, making it a routine part of care. Understanding the impact of bladder cancer treatments on body image ...

Standardized imaging protocols and interpretation criteria are essential for consistent PSMA imaging results across clinical settings. Robust data on the impact of PSMA imaging on patient outcomes is ...

Lu-PSMA-I&T significantly extended rPFS in PSMA-positive mCRPC patients compared to hormone therapy in the ECLIPSE trial. The trial enrolled over 400 patients globally, with primary and secondary ...